It appears Norvartis is going to be the "winner" for the new fall Pandemic vaccine. Here is a little bit of what to expect. Note that cell line technology for pandemic vaccines has been in the works since 2006. As many of you know, I have been deeply involved with this work for the last 10 years. This is the first time I can say that we are very close to mandatory vaccination. The drug companies have 100% product liability protection if it causes harm or death. For details go here: http://drtenpenny.com/Documents/Division_E.pdf Plan locally for how you are going to refuse. I would love to hear ideas from this list about how you are going to ban together in your community to refuse what is bound to be a nasty vaccine. thanks, Dr. Sherri Tenpenny www.DrTenpenny.com +++++++++++++++++++++++++++++++++++++++++++++++++ Rino Rappuoli, Volume: 36, Number: 3 - Autumn 2006 Cell-Culture-Based Vaccine Production: Technological Options The next generation of influenza vaccines will be cell-culture-based for seasonal influenza and for pandemics. http://www.nae.edu/cms/Publications/TheBridge/Archives/7398/7638.aspx The complete characterization of the cell line is required to meet licensing requirements in any country, and selecting the most appropriate approach for a cell-culture vaccine process must be based on growth rates, yields, and regulatory obstacles. Current cell lines being used to express the influenza virus are: PerC.6, a proprietary formulation by Crucell; EBx™, a stem cell line derived from chicken embryos by a member of the Sigma-Aldrich Group; VERO, a kidney cell from the African green monkey; and Madin-Darby canine kidney (MDCK) cells. FYI: Crucell’s PER.C6® cell line is derived from a single, human retina-derived cell, which was purposely immortalized using recombinant DNA technology. http://www.crucell.com/Description The new vaccine will probably also contain MF59, a squalene-containing adjuvant owned by Novartis. MF59 was approved for a flu vaccine in Italy for the elderly but has not been used in a licensed US vaccine. It was trialled for avian flu vaccines and other unlicensed vaccines. Some anticipate more autoimmune reactions as a result of this adjuvant, which stimulates relatively strong immunity. Gary Matsumoto's wonderful book, "Vaccine A" describes the horribly disabling side effects of MF59 in nearly all experimental mice. http://www.webwire.com/ViewPressRel.asp?aId=97032